TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.39 -0.02 (-4.86%) -0.01 (-2.58%) 0.0 (0.04%) -0.01 (-2.61%) --- --- -0.02 (-4.86%) -0.02 (-4.86%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.1918
Diluted P/E:
-0.1918
RSI(14) 1m:
39.63
VWAP:
0.38
RVol:

Events

Period Kind Movement Occurred At

Related News